Sarilumab Effect on the Pharmacokinetics of Simvastatin
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the effect of a single 200 mg subcutaneous injection of sarilumab on the
pharmacokinetics of simvastatin in patients with rheumatoid arthritis
Secondary Objective:
To describe the safety and efficacy (exploratory) of sarilumab